Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?

NCT01197469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Pulmonary Hypertension

Interventions

DRUG: Tadalafil
DRUG: Placebo

Sponsor

University of Dundee

Collaborators

[object Object]
[object Object]
[object Object]